On Sep, 2019, Xantho Bio. successfully obtained a permit from the US FDA to carry out a multi-tasked, phase I/IIa trial for a new botanic drug with dermotology use.
On Sep, 2019, Xantho Bio. successfully obtained a permit from the US FDA to carry out a multi-tasked, phase I/IIa trial for a new botanic drug with dermotology use.